更新版极早产儿结局预测模型在Vermont Oxford网络中的验证评估
更新模型在大型美国队列中区分度中等(C统计量0.74和0.73),且出生医院对生存预测的贡献与胎龄相当。
要点
- 更新模型预测极早产儿生存的C统计量在2006-2012验证队列为0.74,2013-2016为0.73。
- 出生医院对生存预测的贡献与胎龄相当(均约20%),低于其他因素合计(60%)。
- 模型需定期更新,因生存率随时间变化。
核心结论
- 使用已知因素更新的极早产儿生存预测模型在大型美国队列中表现中等,且出生医院对结局预测贡献显著。
- 因生存率随时间变化,该模型需要定期更新。
研究设计与样本
- 预后研究,纳入2006年1月1日至2016年12月31日NRN 19个中心(衍生队列)和VON 637个中心(验证队列)的观察性队列。
- VON队列覆盖超过85%的合格美国出生。
主要发现
- NRN队列4176例积极治疗婴儿(48%女性,平均胎龄24.2周)生存率为63%,原模型时代3702例婴儿生存率为62%。
- 模型C统计量在2006-2012验证队列为0.74,在2013-2016验证队列为0.73。
- 决策曲线分析显示更新模型相比仅用胎龄的预测方法具有预测优势。
- 出生医院对生存预测的贡献与胎龄相当(20%),但低于其他因素合计(60%)。
临床怎么用
- 更新模型可用于美国极早产儿生存预测,但需注意其区分度中等且出生医院影响显著。
- 临床咨询时应考虑出生医院因素对极早产儿结局的影响。
局限性
- 模型预测表现仅为中等(C统计量0.73-0.74),且生存率随时间变化需定期更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN) extremely preterm birth outcome model is widely used for prognostication by practitioners caring for families expecting extremely preterm birth. The model provides information on mean outcomes from 1998 to 2003 and does not account for substantial variation in outcomes among US hospitals. OBJECTIVE: To update and validate the NRN extremely preterm birth outcome model for most extremely preterm infants in the United States. DESIGN, SETTING, AND PARTICIPANTS: This prognostic study included 3 observational cohorts from January 1, 2006, to December 31, 2016, at 19 US centers in the NRN (derivation cohort) and 637 US centers in Vermont Oxford Network (VON) (validation cohorts). Actively treated infants born at 22 weeks' 0 days' to 25 weeks' 6 days' gestation and weighing 401 to 1000 g, including 4176 in the NRN for 2006 to 2012, 45 179 in VON for 2006 to 2012, and 25 969 in VON for 2013 to 2016, were studied. VON cohorts comprised more than 85% of eligible US births. Data analysis was performed from May 1, 2017, to March 31, 2019. EXPOSURES: Predictive variables used in the original model, including infant sex, birth weight, plurality, gestational age at birth, and exposure to antenatal corticosteroids. MAIN OUTCOMES AND MEASURES: The main outcome was death before discharge. Secondary outcomes included neurodevelopmental impairment at 18 to 26 months' corrected age and measures of hospital resource use (days of hospitalization and ventilator use). RESULTS: Among 4176 actively treated infants in the NRN cohort (48% female; mean [SD] gestational age, 24.2 [0.8] weeks), survival was 63% vs 62% among 3702 infants in the era of the original model (47% female; mean [SD] gestational age, 24.2 [0.8] weeks). In the concurrent (2006-2012) VON cohort, survival was 66% among 45 179 actively treated infants (47% female; mean [SD] gestational age, 24.1 [0.8] weeks) and 70% among 25 969 infants from 2013 to 2016 (48% female; mean [SD] gestational age, 24.1 [0.8] weeks). Model C statistics were 0.74 in the 2006-2012 validation cohort and 0.73 in the 2013-2016 validation cohort. With the use of decision curve analysis to compare the model with a gestational age-only approach to prognostication, the updated model showed a predictive advantage. The birth hospital contributed equally as much to prediction of survival as gestational age (20%) but less than the other factors combined (60%). CONCLUSIONS AND RELEVANCE: An updated model using well-known factors to predict survival for extremely preterm infants performed moderately well when applied to large US cohorts. Because survival rates change over time, the model requires periodic updating. The hospital of birth contributed substantially to outcome prediction.
引用
- Rysavy MA, Horbar JD, Bell EF, et al. Assessment of an Updated Neonatal Research Network Extremely Preterm Birth Outcome Model in the Vermont Oxford Network. JAMA Pediatr. 2020. PMID: 32119065. doi:10.1001/jamapediatrics.2019.6294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。